Lantern Pharma Inc (LTRN)

07:05 AM

Is Lantern Pharma Inc. stock vulnerable to regulatory risksJuly 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com

07:05 AM

04:50 AM

Is Lantern Pharma Inc. stock oversold or undervaluedTrade Signal Summary & Risk Managed Investment Strategies - newser.com

04:50 AM

04:35 AM

How Lantern Pharma Inc. stock reacts to global recession fearsEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com

04:35 AM

01:06 AM

How Lantern Pharma Inc. stock performs in weak economyQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com

01:06 AM

01:50 AM

Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows - Gadsden Times

01:50 AM

Nov 16, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialQuarterly Trade Report & Daily Stock Trend Reports - newser.com

Nov 16, 2025

Nov 16, 2025

Can Lantern Pharma Inc. stock deliver consistent earnings growthMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com

Nov 16, 2025

Nov 15, 2025

Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely - Yahoo Finance

Nov 15, 2025

Nov 15, 2025

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 15, 2025

Nov 14, 2025

Lantern Pharma’s Earnings Call: Progress and Funding Needs - TipRanks

Nov 14, 2025

Nov 14, 2025

Lantern Pharma’s Q3 2025: Clinical and AI Progress - TipRanks

Nov 14, 2025

Nov 13, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Q3 2025 Results and Highlights AI-Driven Clinical Progress - Digital Journal

Nov 13, 2025

Nov 13, 2025

Transcript : Lantern Pharma Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener

Nov 13, 2025

Nov 13, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com

Nov 13, 2025

Nov 13, 2025

LTRN: Pivotal quarter with clinical milestones, AI platform advances, and cash runway into Q3 2026 - TradingView

Nov 13, 2025

Nov 13, 2025

Earnings call transcript: Lantern Pharma Q3 2025 sees stock rise after earnings - Investing.com India

Nov 13, 2025

Nov 13, 2025

Lantern Pharma : Q3 2025 Earnings Call - MarketScreener

Nov 13, 2025

Nov 13, 2025

Lantern Pharma Achieves Key Milestones in Q3 2025 - TipRanks

Nov 13, 2025

Nov 13, 2025

Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire

Nov 13, 2025

Nov 12, 2025

Full technical analysis of Lantern Pharma Inc. stock2025 Short Interest & Community Consensus Picks - newser.com

Nov 12, 2025

Nov 12, 2025

Lantern Pharma Earnings Preview - Benzinga

Nov 12, 2025

Nov 12, 2025

Lake Street Schedules Virtual Meeting for November 20 with LTRN Focus - GuruFocus

Nov 12, 2025

Nov 12, 2025

Lantern Pharma Q3 2025 Earnings Call Transcript - MarketBeat

Nov 12, 2025

Nov 11, 2025

How Lantern Pharma Inc. stock reacts to oil pricesMarket Risk Report & Daily Stock Momentum Reports - newser.com

Nov 11, 2025

Nov 11, 2025

Is Lantern Pharma Inc. stock a buy before product launchesJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com

Nov 11, 2025

Nov 10, 2025

Lantern Pharma (NASDAQ: LTRN) CEO Discusses AI-Driven Cancer Drug Development in FintechTV Interview at NYSE - Digital Journal

Nov 10, 2025

Nov 09, 2025

Lantern Pharma Inc. stock trendline breakdownEarnings Summary Report & Community Trade Idea Sharing - newser.com

Nov 09, 2025

Nov 09, 2025

Is Lantern Pharma Inc. stock attractive for income investorsWatch List & Stepwise Trade Signal Guides - newser.com

Nov 09, 2025

Nov 08, 2025

Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lancaster Eagle-Gazette

Nov 08, 2025

Nov 07, 2025

Lantern Pharma (LTRN) Partners with New to The Street for Extens - GuruFocus

Nov 07, 2025